Press Release
Select category
  • Select category
  • Aerospace & Defense
    • Aircraft Components
    • Aircraft Material
    • Aviation
    • Defense
    • Marine
    • Security
    • Space
    • Technology
  • Agriculture
    • Materials
    • Technology
  • Automotive
    • Automotive Systems
    • Chemical Automotive
    • Component
    • Freight & Logistics
    • Material
    • Technology
    • Transport Mode
    • Utility
    • Vehicle
  • Automotive (CI)
  • Baby Products and supplies
  • BFSI
    • Banking
  • Chemical and Materials
    • Advanced Materials
    • Chemical
    • Coatings and Additives
    • Composites
    • Paints
    • Textile
  • Chemical and Materials (CI)
  • Construction & Manufacturing
    • Agriculture
    • Construction and Improvements
    • Construction Materials
    • Decor
    • Equipment and Machinery
    • Industrial Equipment & Automation
    • Packaging
  • Construction & Manufacturing (CI)
  • Consumer & Goods
    • Baby products and supplies
    • Beauty & Personal Care
    • Consumer
    • Home Products
    • Retail
    • Sports & Fitness
    • Travel
  • Electronics and Semiconductor
    • Communication Equipment
    • Display Technology
    • Electronic Component
    • Electronic Devices
    • Emerging Technologies
    • Security
    • Semiconductor
    • Sensor & Control
    • Technology
  • Electronics and Semiconductor (CI)
  • Energy and Power
    • Conventional Energy
    • Equipment
    • Power
    • Renewable Energy
    • Services
    • Storage and Distribution
    • Technology
    • Utility
  • Energy and Power (CI)
  • Food & Beverage
    • Baby Food
    • Beverages
    • Dairy Products
    • Food Ingredient
    • Food Products
    • Food Services and Hospitality
    • Packaging
    • Processed Food
  • Healthcare
  • Healthcare (CI)
  • Industrial Automation & Equipment
    • Component
  • Information and Communication Technology
    • Communication
    • Data Center
    • Data Center and Networking
    • Emerging Technologies
    • Entertainment Technologies
    • Security
    • Software and Services
    • Technology
  • Information and Communication Technology ICT (CI)
  • Life Science
    • Biotechnology
    • Diagnostics and Biotech
    • Healthcare Equipment
    • Healthcare IT
    • Medical Devices
    • Packaging
    • Pharmaceutical
    • Therapeutic
  • Miscellaneous
    • BFSI
    • Education and Training
  • Uncategorized
Evolve Business Intelligence Evolve Business Intelligence
  • Home
  • About Us
  • Services
  • Market Reports
    • Automotive
      • Component
      • Vehicle
      • Chemical Automotive
      • Technology
      • Freight & Logistics
      • Material
      • Technology
      • Transport Mode
      • Utility
      • Vehicle
    • Chemical and Materials
      • Chemical
      • Advanced Materials
      • Coatings and Additives
      • Composites
      • Paints
      • Textile
    • Aerospace & Defense
      • Marine
      • Security
      • Technology
      • Aircraft Components
      • Aircraft Material
    • Construction & Manufacturing
    • Electronics and Semiconductor
      • Display Technology
      • Electronic Component
      • Electronic Devices
      • Semiconductor
      • Communication Equipment
      • Emerging Technologies
      • Security
      • Sensor & Control
      • Technology
    • Energy and Power
    • Life Science
    • Consumer & Goods
      • Baby products and supplies
      • Beauty & Personal Care
      • Consumer
      • Home Products
    • Information and Communication Technology
      • Emerging Technologies
      • Entertainment Technologies
      • Security
      • Communication
      • Data Center
      • Data Center and Networking
      • Software and Services
      • Technology
  • Competitive Intelligence (CI)
    • Automotive (CI)
    • Chemical and Materials (CI)
    • Construction & Manufacturing (CI)
    • Energy and Power (CI)
    • Electronics and Semiconductor (CI)
    • Healthcare (CI)
    • Information and Communication Technology ICT (CI)
  • Contact Us
Menu
Evolve Business Intelligence Evolve Business Intelligence
Press Release
Life Science
Click to enlarge
Home » Our Report Repository » Global Endometriosis Treatment Market Market Analysis and Global Forecast (2022-2030) with COVID Impact Analysis
Global generative AI market
Global Supply Side Platform (SSP) Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis $4,745.60(Approx. $ 3,475.00)
Back to products
Global generative AI market
Global Metaverse NFT Market Analysis and Global Forecast (2022-2030) with COVID Impact Analysis $4,745.60(Approx. $ 3,475.00)

Global Endometriosis Treatment Market Market Analysis and Global Forecast (2022-2030) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)

Global Endometriosis Treatment Market Research Report: Information By Drug Type (Progestin, Gonadotropins Releasing Hormone Agonists, Oral Contraceptive Pills, Non-Steroidal Anti-Inflammatory Drugs, and Others) By Treatment Type (Pain Management and Hormonal Therapies), By Distribution Channel (Hospital Pharmacies, E-Pharmacies, Retail Pharmacies, and Others) and Region — Forecast till 2030

Report Code: EB_ICT | Page: 160 | Published Date: Upcoming

Category: Healthcare Tags: Endometriosis Treatment Analysis, Endometriosis Treatment Companies, Endometriosis Treatment Forecast, Endometriosis Treatment Growth, Endometriosis Treatment Industry, Endometriosis Treatment Restraints, Endometriosis Treatment Share, Endometriosis Treatment Size, Endometriosis Treatment Trends
Share:
  • Description
  • Table of Contents
  • Connect to Analyst
  • Research Methodology
Description

Market Overview

The global Endometriosis Treatment market size is projected to reach approximately $ 2.332 billion by 2030, at a CAGR of 3.4% from 2022 to 2030. Endometriosis is a condition in which tissue that lines the inner part of the uterus grows outside the uterus. It causes pain, scarring, and bowel problems. Endometriosis is a condition that may cause internal bleeding as well as pain. This condition is characterized by having endometrial tissue growing in places where it’s not supposed to grow, like the fallopian tubes, ovaries, and pelvis. Endometriosis causes many symptoms, including pain in the pelvic region, which is typical for women during different periods of the month. It may also result in pain during intercourse and excessive bleeding.

COVID-19 Impact Analysis

The Endometriosis Treatment market was severely impacted by the spread of the Coronavirus pandemic. The market was affected due to the spread of the disease to other countries. In addition, the spread of the coronavirus has led to the lack of quality treatment in the market. This is because most countries have banned the entry of products that are used in the treatment of endometriosis. In addition, there is also no government support to promote products that are used in the treatment of the disease.

Market Dynamics

The Endometriosis Treatment market is projected to grow on account of the availability and research into new drugs. This will be supported by an increase in Endometriosis prevalence, a robust pipeline for potential advanced treatment models and trends, and increased awareness about Endometriosis.

Drivers:

⮚     Increased Research on the Development of New Drugs

Increased Research activities and increased funding from the governments of various countries to develop new drugs for the global endometriosis treatment market are expected to be a major drivers of the market growth forecasted period. In 2017, drug manufacturer AbbVie submitted an application to the US FDA for a new drug called Elagolix. They are working in cooperation with a company called Neurocrine Biosciences Inc. Elagolix is an orally administered gonadotropin-releasing hormone (GnRH) antagonist which is being evaluated for the management of pain during endometriosis.

Restraint:

  • Lack of non-invasive diagnostic tests in the market

Women with endometriosis typically wait a long time before receiving the necessary diagnosis. Women do not seek help timely, during which their disease can progress significantly, potentially impacting their fertility. There is a long-known delay in the diagnosis of endometriosis because the condition can be definitively diagnosed only via laparoscopy, which is an invasive surgical procedure. However, better diagnostic techniques are becoming more prevalent, such as biomarkers. These can help hasten the diagnosis process and avoid invasive surgery if unnecessary.

Opportunity:

⮚     Growing Prevalence and Awareness of Endometriosis

The rising prevalence of endometriosis is leading to an increase in awareness among women regarding treatment options and research developments. With a significant increase in the occurrence of this disease, it is clear that more people are willing to invest in research and development. This allows the market to grow and provides additional opportunities.

 

Segment Overview

By Drug Type

Based on the Drug Type, the Endometriosis Treatment market is segmented based on Progestin, Gonadotropins Releasing Hormone Agonists, Oral Contraceptive Pills, Non-Steroidal Anti-Inflammatory Drugs, and Others. The Oral Contraceptive Segment is anticipated to account for the large market share. Oral contraceptives are the first-line treatment for patients who do not have contraindications. They are highly effective in preventing recurrent pelvic pain and associated endometriosis lesions. However, they are associated with possible side effects such as changes in mood, nausea, and an elevated blood pressure level.

By Treatment Type

Based on Treatment Type, the global Endometriosis Treatment market has been divided into Pain Management and Hormonal Therapies. The Hormonal Therapies segment is expected to hold the largest market share. This form of treatment is the most common one due to its effectiveness in decreasing estrogen production and preventing periods from coming.

By Distribution Channel

Based on Distribution Channel, the global Endometriosis Treatment market has been divided into Hospital Pharmacies, E-Pharmacies, Retail Pharmacies, and Others. The Hospital Pharmacies and Retail Pharmacies segments are expected to hold the largest market share. The high patient pool in hospitals and visiting retailers and the high cost of the medical treatment contribute to this result

Global Endometriosis Treatment Market Share, by Segmentation

Regional Analysis

Based on region, the global Endometriosis Treatment market has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America is projected to dominate the use of the Endometriosis Treatment market followed by the Asia-Pacific and Europe regions.

North America Market

North America is expected to account for the highest Endometriosis Treatment revenue in the upcoming years. The prevalence of chronic gynecological disorders like Endometriosis has been rising in the United States and around the world. Women are now more open to talking about their reproductive health, including their menstrual cycle and menopause, which is leading to increased awareness of female reproductive health. Advances in technology have also paved the way for new services and treatments.

Asia-Pacific Market

The Asia-Pacific region is expected to become the fastest-growing Endometriosis Treatment market over the forecast period due to the government initiatives to improve women’s health and safety. In 2018, the government of Australia allocated about $2.5 million for research in the field of Endometriosis.

Competitive Landscape

The market comprises tier-1, tier-2, and local players. With their wide product portfolios, tier-1 and tier-2 players have a global reach. Because of their strategic innovations and broad regional presence, companies such as Astra Zeneca Plc., Eli Lilly and Company, Astellas Pharma, Bayer AG, Meditrina Pharmaceuticals, Abbvie, PfizerInc, Takeda Pharmaceutica, and Neurocrine Biosciences Inc, lead the global Endometriosis Treatment business. To increase their market position and attract a wide consumer base, the businesses are employing various strategies, such as growth, product releases, and alliances.

Prominent Players:

  • Eli Lilly and Company
  • AstraZeneca Plc.
  • Bayer AG
  • Astellas Pharma
  • Abbvie
  • Meditrina Pharmaceuticals
  • Pfizer Inc.
  • Neurocrine Biosciences Inc.
  • Takeda Pharmaceutical Company

In 2018, Bayer collaborated with Evotec and announced phase I trials for a new drug that is a treatment for endometriosis

Scope of the Report

Global Endometriosis Treatment Market, by Drug Type

  • Progestin
  • Gonadotropins Releasing Hormone Agonists
  • Oral Contraceptive Pills
  • Non-Steroidal Anti-Inflammatory Drugs
  • Others

Global Endometriosis Treatment Market, by Treatment Type

  • Pain Management
  • Hormonal Therapies

Global Endometriosis Treatment Market, by Distribution Channel

  • Hospital Pharmacies
  • E-Pharmacies
  • Retail Pharmacies
  • Others

Global Endometriosis Treatment Market, by Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Rest of Asia Pacific
  • Rest of the World

 

Parameters Indicators
Market Size 2030: $ 2.332  Billion
CAGR 3.4% CAGR (2022-2030)
Base year 2021
Forecast Period 2022-2030
Historical Data 2020
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Key Segmentations Drug Type, Treatment Type, Distribution Channel
Geographies Covered North America, Europe, Asia-Pacific, Latin America, Middle East, Africa
Key Vendors Astra Zeneca Plc., Eli Lilly and Company, Astellas Pharma, Bayer AG, Meditrina Pharmaceuticals, Abbvie, PfizerInc, Takeda Pharmaceutica, and Neurocrine Biosciences Inc
Key Market Opportunities Growing Prevalence and Awareness of Endometriosis
Key Market Drivers Increased Research on Development of New Drugs

 

REPORT CONTENT BRIEF:

  • High-level analysis of the current and future Endometriosis Treatment market trends and opportunities
  • Detailed analysis of current market drivers, restraining factors, and opportunities in the future
  • Endometriosis Treatment market historical market size for the year 2020, and forecast from 2021 to 2028
  • Endometriosis Treatment market share analysis at each product level
  • Competitor analysis with a detailed insight into its product segment, financial strength, and strategies adopted.
  • Identifies key strategies adopted including product launches and developments, mergers and acquisitions, joint ventures, collaborations, and partnerships as well as funding taken and investment done, among others.
  • To identify and understand the various factors involved in the global Endometriosis Treatment market affected by the pandemic
  • To provide a detailed insight into the major companies operating in the market. The profiling will include the financial health of the company past 2-3 years with segmental and regional revenue breakup, product offering, recent developments, SWOT analysis, and key strategies.

For more details mail us at

[email protected]

Ask a question / additional requirement

Press Release

  • The Global Double Chamber Injection Devices Market Is Estimated To Record a CAGR of Around 9.99% During The Forecast Period

    The Global Double Chamber Injection Devices Market Is Estimated To Record a CAGR of Around 9.99% During The Forecast Period

    August 26, 2023

  • The Global Flexible Printed Circuit Board Market Is Estimated To Record a CAGR of Around 11.60% During The Forecast Period

    The Global Flexible Printed Circuit Board Market Is Estimated To Record a CAGR of Around 11.60% During The Forecast Period

    August 26, 2023

  • The Global Clinical Biomarkers Market Is Estimated To Record a CAGR of Around 16.7% During The Forecast Period

    The Global Clinical Biomarkers Market Is Estimated To Record a CAGR of Around 16.7% During The Forecast Period

    August 26, 2023

  • The Global Data Center Environmental Monitoring System Market Is Estimated To Record a CAGR of Around 8.45% During The Forecast Period

    The Global Data Center Environmental Monitoring System Market Is Estimated To Record a CAGR of Around 8.45% During The Forecast Period

    August 26, 2023

  • The Global Data Center Networking Market Is Estimated To Record a CAGR of Around 15.55% During The Forecast Period

    The Global Data Center Networking Market Is Estimated To Record a CAGR of Around 15.55% During The Forecast Period

    August 26, 2023

  • The Global Graft Delivery Device Market Is Estimated To Record a CAGR of Around 12.99% During The Forecast Period

    The Global Graft Delivery Device Market Is Estimated To Record a CAGR of Around 12.99% During The Forecast Period

    August 26, 2023

  • The Global HubSpot Consulting and Implementation Market Is Estimated To Record a CAGR of Around 15.23% During The Forecast Period

    The Global HubSpot Consulting and Implementation Market Is Estimated To Record a CAGR of Around 15.23% During The Forecast Period

    August 26, 2023

  • The Global Liquid Skin Protectors Market Is Estimated To Record a CAGR of Around 10.64% During The Forecast Period

    The Global Liquid Skin Protectors Market Is Estimated To Record a CAGR of Around 10.64% During The Forecast Period

    August 26, 2023

  • The Global Lithium-Ion Battery Energy Storage System Market Is Estimated To Record a CAGR of Around 15.5% During The Forecast Period

    The Global Lithium-Ion Battery Energy Storage System Market Is Estimated To Record a CAGR of Around 15.5% During The Forecast Period

    August 26, 2023

  • The Global Machine Safety Market Is Estimated To Record a CAGR of Around 6.9% During The Forecast Period

    The Global Machine Safety Market Is Estimated To Record a CAGR of Around 6.9% During The Forecast Period

    August 26, 2023

Endometriosis Treatment Market Market FAQs

  1. What is the study period of this market?
  • The study period of the global Endometriosis Treatment market is 2020 – 2030
  1. What is the growth rate of the global Endometriosis Treatment market?
  • The global Endometriosis Treatment market is growing at a CAGR of ~ 4% over the next 7 years
  1. Which region has the highest growth rate in the global Endometriosis Treatment market?
  • Asia Pacific is expected to register the highest CAGR during 2022-2030
  1. Which region has the largest share in the global Endometriosis Treatment market?
  • North America holds the largest share in 2021
  1. Who are the key players in the global Endometriosis Treatment market?
  • Astra Zeneca Plc., Eli Lilly and Company, Astellas Pharma, Bayer AG, Meditrina Pharmaceuticals, Abbvie, PfizerInc, Takeda Pharmaceutica, and Neurocrine Biosciences Inc. are the major companies operating in the global Endometriosis Treatment
  1. Do you offer Post Sale Support?
  • Yes, we offer 16 hours of analyst support to solve the queries
  1. Do you sell particular sections of a report?
  • Yes, we provide regional as well as country-level reports. Other than this we also provide a sectional report. Please get in contact with our sales representatives.

 

 

Table of Contents

Table of Contents

Chapter 1.   Executive Summary

Chapter 2.   Scope Of Study

                      2.1.   Market Definition

                      2.2.   Scope Of The Study

                                2.2.1.   Objectives of Report

                                2.2.2.   Limitations

                      2.3.   Market Structure

Chapter 3.   Evolve BI Methodology

Chapter 4.   Market Insights and Trends

                      4.1.   Supply/ Value Chain Analysis

                                4.1.1.   Raw Application Providers

                                4.1.2.   Manufacturing Process

                               4.1.3.   Distributors/Retailers

                                4.1.4.   End Users

                      4.2.   Porter’s Five Forces Analysis

                                4.2.1.   Threat Of New Entrants

                               4.2.2.    Bargaining Power Of Buyers

                                4.2.3.   Bargaining Power Of Suppliers

                                4.2.4.   Threat Of Substitutes

                                4.2.5.   Industry Rivalry

                      4.3.   Impact Of COVID-19 on Endometriosis Treatment

                                4.3.1.   Impact on Market Size

                                4.3.2.   End-User Trend, Preferences, and Budget Impact

                                4.3.3.   Regulatory Framework/Government Policies

                                4.3.4.   Key Players' Strategy to Tackle Negative Impact

                                4.3.5.   Opportunity Window

                     4.4.   Technology Overview

                      4.5.   Macro factor

                      4.6.   Micro Factor

                        4.7.   Demand Supply Gap Analysis of Endometriosis Treatment

                        4.8.   Import Analysis of Endometriosis Treatment

                        4.9.   Export Analysis of Endometriosis Treatment

Chapter 5.   Market Dynamics 

                      5.1.   Introduction

                      5.2.   DROC Analysis

                                5.2.1.   Drivers

                                5.2.2.   Restraints

                                5.2.3.   Opportunities

                                5.2.4.   Challenges

                      5.3.   Patent Analysis

                      5.4.   Industry Roadmap

                     5.5.   Parent/Peer Market Analysis

Chapter 6.   Global Endometriosis Treatment, By Drug Type

                      6.1.   Introduction

                      6.2.   Progestin

                      6.3.   Gonadotropins Releasing Hormone Agonists

                      6.4.   Oral Contraceptive Pills

                      6.5.   Non-Steroidal Anti-Inflammatory Drugs

                      6.6     Others

Chapter 7.   Global Endometriosis Treatment, By Treatment Type

                      7.1.   Introduction

                      7.2.   Hormonal Therapies

                      7.3.   Pain Management

Chapter 8.   Global Endometriosis Treatment, By Distribution Channel

                      8.1.   Introduction

                      8.2.   Hospital Pharmacies

                      8.3.   E-Pharmacies

                      8.4    Retail Pharmacies

                      8.5    Others

Chapter 9.   Global Endometriosis Treatment, By Region

                      9.1.   Introduction

                      9.2.   North America

                                9.2.1.   Introduction

                                9.2.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                9.2.3.   Market Size and Forecast, By Country, 2020 - 2028

                               9.2.4.   Market Size and Forecast, By Product Type, 2020 - 2028

                                9.2.5.   Market Size and Forecast, By Application, 2020 – 2028

                                9.2.6.   US

                                              9.2.6.1.   Introduction

                                               9.2.6.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                               9.2.6.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                               9.2.6.4.   Market Size and Forecast, By Application, 2020 - 2028

                                9.2.7.   Canada

                                               9.2.7.1.   Introduction

                                               9.2.7.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                               9.2.7.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                              9.2.7.4.   Market Size and Forecast, By Application, 2020 - 2028

                      9.3.   Europe

                                9.3.1.   Introduction

                                9.3.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                9.3.3.   Market Size and Forecast, By Country, 2020 - 2028

                                9.3.4.   Market Size and Forecast, By Product Type, 2020 - 2028

                                9.3.5.   Market Size and Forecast, By Application, 2020 – 2028

                                9.3.6.   Germany

                                               9.3.6.1.   Introduction

                                               9.3.6.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                               9.3.6.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                               9.3.6.4.   Market Size and Forecast, By Application, 2020 - 2028

                                9.3.7.   France

                                               9.3.7.1.   Introduction

                                               9.3.7.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                               9.3.7.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                               9.3.7.4.   Market Size and Forecast, By Application, 2020 - 2028

                                9.3.8.   UK

                                              9.3.8.1.   Introduction

                                               9.3.8.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                               9.3.8.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                               9.3.8.4.   Market Size and Forecast, By Application, 2020 - 2028

                                9.3.9.   Italy

                                               9.3.9.1.   Introduction

                                              9.3.9.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                               9.3.9.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                              9.3.9.4.    Market Size and Forecast, By Application, 2020 - 2028

                                9.3.10.   Rest Of Europe

                                               9.3.10.1.   Introduction

                                               9.3.10.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                               9.3.10.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                               9.3.10.4.   Market Size and Forecast, By Application, 2020 - 2028

                      9.4.   Asia-Pacific

                                9.4.1.   Introduction

                               9.4.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                9.4.3.   Market Size and Forecast, By Country, 2020 - 2028

                                9.4.4.   Market Size and Forecast, By Product Type, 2020 - 2028

                                9.4.5.   Market Size and Forecast, By Application, 2020 - 2028

                                9.4.6.   China

                                               9.4.6.1.   Introduction

                                              9.4.6.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                               9.4.6.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                               9.4.6.4.   Market Size and Forecast, By Application, 2020 - 2028

                                9.4.7.   India

                                               9.4.7.1.   Introduction

                                               9.4.7.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                               9.4.7.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                               9.4.7.4.   Market Size and Forecast, By Application, 2020 - 2028

                               9.4.8.   Japan

                                               9.4.8.1.   Introduction

                                               9.4.8.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              9.4.8.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                               9.4.8.4.   Market Size and Forecast, By Application, 2020 - 2028

                                9.4.9.   South Korea

                                               9.4.9.1.   Introduction

                                               9.4.9.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                               9.4.9.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                               9.4.9.4.   Market Size and Forecast, By Application, 2020 - 2028

                                9.4.10.   Rest Of Asia-Pacific

                                               9.4.10.1.   Introduction

                                               9.4.10.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              9.4.10.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                               9.4.10.4.   Market Size and Forecast, By Application, 2020 - 2028

                      9.5.   Rest Of The World (RoW)

                                9.5.1.   Introduction

                                9.5.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                9.5.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                               9.5.4.   Market Size and Forecast, By Application, 2020 - 2028

                                9.5.5.   Market Size and Forecast, By Region, 2020 - 2028

                                9.5.6.   South America

                                              9.5.6.1.   Introduction

                                               9.5.6.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                               9.5.6.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                               9.5.6.4.   Market Size and Forecast, By Application, 2020 - 2028

                                9.5.7.   Middle East and Africa

                                               9.5.7.1.   Introduction

                                               9.5.7.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                               9.5.7.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                               9.5.7.4.   Market Size and Forecast, By Application, 2020 - 2028

Chapter 10.    Competitive Landscape

                      10.1.   Introduction

                      10.2.   Vendor Share Analysis, 2020/Key Players Positioning, 2020

Chapter 11.   Company Profiles

                      11.1.   Astra Zeneca Plc.

                                11.1.1.   Business Overview

                                11.1.2.   Financial Analysis

                                11.1.3.   Product Portfolio

                                11.1.4.   Recent Development and Strategies Adopted

                                11.1.5.   SWOT Analysis

                      11.2.  Eli Lilly and Company

                               11.2.1.   Business Overview

                                11.2.2.   Financial Analysis

                                11.2.3.   Product Portfolio

                                11.2.4.   Recent Development and Strategies Adopted

                               11.2.5.   SWOT Analysis

                      11.3.   Astellas Pharma

                                11.3.1.   Business Overview

                                11.3.2.   Financial Analysis

                                11.3.3.   Product Portfolio

                                11.3.4.   Recent Development and Strategies Adopted

                                11.3.5.   SWOT Analysis

                      11.4.   Bayer AG

                                11.4.1.   Business Overview

                               11.4.2.   Financial Analysis

                                11.4.3.   Product Portfolio

                                11.4.4.   Recent Development and Strategies Adopted

                                11.4.5.   SWOT Analysis

                      11.5.   Meditrina Pharmaceuticals

                                11.5.1.   Business Overview

                               11.5.2.   Financial Analysis

                                11.5.3.   Product Portfolio

                                11.5.4.   Recent Development and Strategies Adopted

                                11.5.5.   SWOT Analysis

                     11.6.   Abbvie

                                11.6.1.   Business Overview

                                11.6.2.   Financial Analysis

                                11.6.3.   Product Portfolio

                                11.6.4.   Recent Development and Strategies Adopted

                                11.6.5.   SWOT Analysis

                      11.7.   Pfizer Inc.

                               11.7.1.   Business Overview

                                11.7.2.   Financial Analysis

                                11.7.3.   Product Portfolio

                                11.7.4.   Recent Development and Strategies Adopted

                               11.7.5.   SWOT Analysis

                      11.8.   Takeda Pharmaceutica

                                11.8.1.   Business Overview

                                11.8.2.   Financial Analysis

                                11.8.3.   Product Portfolio

                                11.8.4.   Recent Development and Strategies Adopted

                                11.8.5.   SWOT Analysis

                      11.9.   Neurocrine Biosciences Inc.

                                11.9.1.   Business Overview

                                11.9.2.   Financial Analysis

                                11.9.3.   Product Portfolio

                                11.9.4.   Recent Development and Strategies Adopted

                                11.9.5.   SWOT Analysis

              Chapter 12.   Key Takeaways

Connect to Analyst

Connect to Analyst

 

 

Research Methodology

Research Methodology

Related products

Life Science

Heart Rate Monitor Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)
Heart Rate Monitor Market Research Report: Information By Product (Wearable and Non-Wearable), By End Users (Hospital and Clinics, Sports Medicine Centers, Professionals, and Individuals), By Indication (Sports and Medical), and By Region — Forecast till 2033
Add to cart
Quick view
Life Science

COVID Testing Kit Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)

Global COVID Testing Kit Market By Type (Rapid Test Kit, RT-PCR, Others), By Application (Hospitals, Clinics, Others), and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends, and Forecast from 2021 to 2028

Report Code: EB_LS_1098 | Page: 163 | Published Date: April 2021
Add to cart
Quick view
Life Science

Oxyclozanide Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)
Oxyclozanide Market Research Report: Information By Type (Content 98%, Content 99%, Other), By Application (Injectables, Oral Liquids, Feed Additives), and by Region — Forecast till 2033
Add to cart
Quick view
Life Science

Desiccant Air Breathers market Analysis and Global Forecast (2023 – 2033) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)
Desiccant Air Breathers Market Research Report: Information By Silica Content By Working Environment (Disposable Stationary Application, Limited Space Application, High Humidity / High Dust Application, Extreme Environment Application, High Vibration Application, Heavy Duty Application, Caustic Fumes/Gaseous Application)
Press Release :https://evolvebi.com/desiccant-air-breathers-market-is-estimated-to-record-a-cagr-of-around-5-58-during-the-forecast-period-2/
Add to cart
Quick view
Life Science

Healthcare Consulting Services Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)
Healthcare Consulting Services Market Research Report: Information By Services (Strategic Management Consulting, Financial Management Consulting, Information Technology Consulting, Human Resource Consulting, Others), By End-use (Pharmaceutical Companies, Hospitals, Insurance Companies, Government Organizations, Other), and Region — Forecast till 2033
Add to cart
Quick view
Healthcare

Global Histology Equipment Market Analysis and Global Forecast (2022-2030) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)
The global Histology Equipment market size is projected to reach approximately $7.93Billion by 2030, at a CAGR of 4.7% from 2022 to 2030. Report Code: EB_ICT | Page: 170 | Published Date: Upcoming
Add to cart
Quick view
Life Science

Aesthetic Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)
Aesthetic Market Research Report: By Procedure (Invasive Procedures, Non-invasive Procedures), By Gender (Male, Female), By End-User (Clinics, Hospitals and Medical Spas, Beauty Centers, Home Care), and by Region — Forecast till 2033
Add to cart
Quick view
Life Science

Mammography Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)
Mammography Market Research Report: Information By Product (Film Screen Systems, Digital Systems, Analog Systems, 3D Systems), By Technology (Breast Tomosynthesis, CAD Mammography, Digital Mammography), By End-user (Hospitals, Specialty Clinics, Diagnosis Centers, Others), and By Region — Forecast till 2033
Add to cart
Quick view

Uncover Market Secrets: Get Market Insights in Your Inbox 🚀

Join over 5,000 professionals staying ahead of industry trends. Subscribe to our weekly market research newsletter.

Join our community of industry leaders and stay ahead of the curve. Subscribe now for data-driven market intelligence and strategic recommendations that will set your business on a path to success! Don't miss out on our FREE exclusive insights – sign up today and soar above your competition!🚀

cropped-evolvebi-Logo-2021-1.png
M/S Evolve Business Intelligence C-218, 2nd floor, M-Cube, N.H. – 48, Balitha, Vapi, Valsad- Gujarat
Email: [email protected]

Email: [email protected]

  • Important Links
    • About Evolvebi
    • Competitive Intelligence
    • Become a reseller
    • Contact Us
  • Top Search By Countries Hot
    • United State
    • Europe
    • Asia Pacific
    • Middle East & Africa
    • Latin America

© 2021 - 2023 Evolve Business Intelligence. All rights reserved. Developed by Nectron

Privacy Policy | Terms and Conditions | Cancellation and Refund policy

  • Home
  • About Us
  • Services
  • Market Reports
    • Automotive
      • Component
      • Vehicle
      • Chemical Automotive
      • Technology
      • Freight & Logistics
      • Material
      • Technology
      • Transport Mode
      • Utility
      • Vehicle
    • Chemical and Materials
      • Chemical
      • Advanced Materials
      • Coatings and Additives
      • Composites
      • Paints
      • Textile
    • Aerospace & Defense
      • Marine
      • Security
      • Technology
      • Aircraft Components
      • Aircraft Material
    • Construction & Manufacturing
    • Electronics and Semiconductor
      • Display Technology
      • Electronic Component
      • Electronic Devices
      • Semiconductor
      • Communication Equipment
      • Emerging Technologies
      • Security
      • Sensor & Control
      • Technology
    • Energy and Power
    • Life Science
    • Consumer & Goods
      • Baby products and supplies
      • Beauty & Personal Care
      • Consumer
      • Home Products
    • Information and Communication Technology
      • Emerging Technologies
      • Entertainment Technologies
      • Security
      • Communication
      • Data Center
      • Data Center and Networking
      • Software and Services
      • Technology
  • Competitive Intelligence (CI)
    • Automotive (CI)
    • Chemical and Materials (CI)
    • Construction & Manufacturing (CI)
    • Energy and Power (CI)
    • Electronics and Semiconductor (CI)
    • Healthcare (CI)
    • Information and Communication Technology ICT (CI)
  • Contact Us
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.
More info Accept
I allow the Site owner to contact me via email/phone to discuss this enquiry. (If you want to know more about the way this site handles the data, then please go through our privacy policy).
Brought to you by WisdmLabs: WordPress Development Experts

Sending...